MedPath

Management of Constitutional Thinness Through an Adapted Physical Activity Program, Whether or Not Associated With Food Supplementation. Interventional Study Compared to Matched Controls: NUTRILEAN + Study

Not Applicable
Conditions
Constitutionally Lean Women
Healthy Normal Weight Women
Interventions
Behavioral: Physical training alone
Behavioral: physical training + protein intake
Registration Number
NCT04749706
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

The main aim of the present study is to compare the effect of a 12-week physical activity program on body weight gain and body composition changes between normal weight and constitutionally lean individuals. The second objective will be to question the potential additional effect of a protein supplementation coupled to the physical training intervention on body wright and body composition in constitutionally lean women.

Detailed Description

After a medical inclusion visit, the participants will realize a maximal aerobic test at the university hospital as well as a body composition analysis, a blood sample will be taken, their resting metabolic rate will be assessed as well as their energy metabolism during a rectangular cycling exercise. Their muscle strength and architecture will be assessed. Their energy intake and eating habits will also be assessed as well as their diet-induced thermogenesis in response to a fixed and an ad libitum meal. Their sleep metabolism will also be assessed using the Dreem technology. Questionnaires will be used to evaluate their daily free living energy intake and accelerometers used to assess their daily physical activity level.

The participants will then perform a 12-week physical activity intervention with 15 of the 30 constitutionally lean one receiving a protein supplementation (randomly assigned). All the measures will be replicated at the end of the intervention as well as 6 weeks after

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
45
Inclusion Criteria

Inclusion criteria common to both groups

  • Adult women aged 18 to 35, having a stable weight for at least 3 months.
  • Body mass index (BMI) ≤ 17.5 kg / m2 (for the "constitutional thinness" group) or 20 kg / m2 ≤ BMI ≤ 25 kg / m2 (for the normal-weighted control group)
  • Able to give informed consent to participate in research.
  • Affiliation to a Social Security scheme.

Inclusion criteria specific to women with constitutional thinness

  • BMI ≤ 17.5 kg / m2
  • Weight stable for at least 3 months
  • No eating disorder
  • No biological markers of undernutrition
  • Absence of secondary amenorrhea

Inclusion criteria specific to normo-weighted subjects

  • 20 kg / m2 ≤ BMI ≤ 25 kg / m2
  • Weight stable for at least 3 months
  • No eating disorder
  • No biological markers of undernutrition
  • Absence of secondary amenorrhea
Exclusion Criteria
  • Pregnant or breastfeeding woman
  • Severe progressive disease
  • Medical or surgical history judged by the investigator to be incompatible with this study
  • Diabetes or any other pathology limiting the application of one or the other trial strategy
  • History of cardiovascular and / or neuro-vascular pathology, and / or cardiovascular and / or neuro-vascular risk factors (excluding obesity / overweight)
  • Surgical intervention in the previous 3 months
  • Taking medications that may interfere with the results of the study
  • Regular practice of intense physical activity (more than 3 physical activity sessions per week)
  • Regular consumption of tobacco or alcohol
  • Special diet
  • Abnormal plasma levels of IGF-1, estradiol, free T3, cortisol and leptin (only for the "constitutional thinness" group)
  • Persons under guardianship or subjects deprived of their liberty by judicial or administrative decision
  • Person in a period of exclusion from another study
  • Refusal of participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
constitutionally lean women - Physical training onlyPhysical training alonewomen will receive the 12-week physical activity intervention
constitutionally lean women - Physical training + proteinsphysical training + protein intakewomen will receive the 12-week physical activity intervention in addition to a protein supplementation
Normal weightPhysical training alonethe normal weight women will receive the 12-week physical activity intervention and serve as a control group.
Primary Outcome Measures
NameTimeMethod
Change in body weight from baselineday 1, day 90, day 145

body weight using a classical scale at different time : baseline, after the 12-week intervention and after 6 weeks of follow-up .

Change in fat free mass compositionday 1, day 90, day 145

fat free mass will be assessed using DXA

Change in fat mass compositionday 1, day 90, day 145

fat mass will be assessed using DXA

Secondary Outcome Measures
NameTimeMethod
Change in LipoxMaxday 1, day 90, day 145

the point of maximal use of lipids during exercise will be assessed during a graded exercise composed of 4 stages of 6 minutes each, using indirect calorimetry.

Change in sleep metabolism assessed with the dreem technology captorsday 1, day 90, day 145

sleep metabolism assessed during a complete night, using the Dreem technology captors that consists in a simple band around the head during the night.

Change in muscle structureday 1, day 90, day 145

muscle structure assessed thanks to muscle echography

Change in triglyceridesday 1, day 90, day 145

triglycerides will be evaluated in blood sample

Change in bone structureday 1, day 90, day 145

the bone structure will be assessed thanks to DXA and pQCT

Change in resting metabolic rateday 1, day 90, day 145

resting metabolic rate assessed using indirect calorimetry during 30 minute rest in a comfortable inclined chair. The is the energy expended at rest in Kilo-Joules.

Change in muscle strengthday 1, day 90, day 145

muscle strength assessed thanks to isometric contraction using Biodex.

Change in cholesterolday 1, day 90, day 145

cholesterol will be evaluated in blood sample

Change in ghrelinday 1, day 90, day 145

ghrelin will be evaluated in blood sample

Change in adiponectinday 1, day 90, day 145

adiponectin will be evaluated in blood sample

Change in thyroid hormonesday 1, day 90, day 145

thyroid hormones will be evaluated in blood sample

Change in Energy intakeday 1, day 90, day 145

Energy Intake will be assessed using a Three-day dietary report (self-reported)

Change in physical activity level measured with an accelerometerday 1, day 90, day 145

The time spent at low-moderate and vigorous physical activity will be assessed using a 7-day accelerometry record

Change in aerobic capacities .day 1, day 90, day 145

aerobic capacities assessed using indirect calorimetry during a graded cycling exercise

Change in Insulinday 1, day 90, day 145

Insulin will be evaluated in blood sample

Change in glycaemia, .day 1, day 90, day 145

glycaemia will be evaluated in blood sample

Change in leptinday 1, day 90, day 145

leptin will be evaluated in blood sample

Trial Locations

Locations (1)

Chu Clermont Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath